Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes - Martin, Julie; Wang, Zhong Q; Zhang, Xian H; Wachtel, Deborah; Volaufova, Julia; Matthews, Dwight E; Cefalu, William T (Diabetes care, 2006)
Keywords: abdominal fat; Adipose Tissue; Adipose Tissue - drug effects; Adult; Aged; Agents; Biological and medical sciences; blood glucose; Chromium; Chromium (Nutrient); Clinical medicine; Diabetes; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - metabolism; Diabetes Mellitus, Type 2 - physiopathology; Diabetes. Impaired glucose tolerance; Diet therapy; Dietary supplements; Disease control; drug effects; drug therapy; Drug Therapy, Combination; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Environmental health; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Female; free fatty acids; gastrointestinal system; glipizide; glucose; glycemic control; Health aspects; Humans; Insulin; Insulin - therapeutic use; insulin resistance; lean body mass; Male; Medical sciences; Medical treatment; Metabolism; Middle Aged; noninsulin-dependent diabetes mellitus; Patients; pharmacology; Phenotype; physiopathology; Picolinic Acids; Picolinic Acids - pharmacology; therapeutic use; Type 2 diabetes; visceral fat; weight gain; Weight Gain - drug effects; United States; Endocrinopathy; Type 2 diabetes; Human; Pancreatic hormone; Sensitivity; Body weight; Chromium; Metabolic diseases; Supplementation; Insulin; Weight gain; Pyridine derivatives